Sartorius Stedim Biotech SA
Sartorius Stedim Biotech SA/ FR0013154002 /
DIM
04.06.2024 11:01:01
|
Zm.
-1,80
|
Wolumen |
Bid11:01:02 |
Ask11:01:01 |
Kapitalizacja Rynkowa |
St. dywidendy |
Wskaźnik C/Z |
179,75EUR
|
-0,99%
|
4 715 Obrót: 849 353,50 |
179,60Wolumen Bid: 86 |
179,85Wolumen Ask: 49 |
16,61 mldEUR |
0,38% |
53,63 |
Opis działalności
Sartorius Stedim Biotech is a leading international supplier of products and services that enable the biopharmaceutical industry to develop and manufacture drugs safely and efficiently. As a total solutions provider, Sartorius Stedim Biotech offers a portfolio covering nearly all steps of biopharmaceutical manufacture. The company focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. Headquartered in Aubagne, France, Sartorius Stedim Biotech is quoted on the Eurolist of Euronext Paris. With its own manufacturing and R&D sites in Europe, North America and Asia and an international network of sales companies, Sartorius Stedim Biotech has a global reach.
Zarząd & Rada nadzorcza
CEO |
Dr. Joachim Kreuzburg |
Zarząd |
Alexandra Gatzemeyer, Dr. René Fáber |
Rada nadzorcza |
Joachim Kreuzburg, René Fáber, Pascale Boissel, Susan Dexter, Romaine Fernandes, Anne-Marie Graffin, Lothar Kappich, Henri Riey |
Kalendarz korporacyjny
Tydz. 29 | 19.07.2024
Raport okresowy/2. kwartał
|
Tydz. 42 | 17.10.2024
Raport okresowy/3. kwartał
|